Gensight Biologics (XPAR:SIGHT) Price-to-Operating-Cash-Flow : (As of May. 20, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics Price-to-Operating-Cash-Flow?

As of today (2024-05-20), Gensight Biologics's share price is €0.394. Gensight Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.52. Hence, Gensight Biologics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Gensight Biologics's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:SIGHT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 27.11
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Gensight Biologics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €-0.17. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.52.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -6.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -3.40% per year.

During the past 12 years, Gensight Biologics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.10% per year. The lowest was -103.70% per year. And the median was 1.95% per year.

Gensight Biologics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Gensight Biologics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gensight Biologics Price-to-Operating-Cash-Flow Chart

Gensight Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Gensight Biologics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gensight Biologics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Gensight Biologics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gensight Biologics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gensight Biologics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Gensight Biologics's Price-to-Operating-Cash-Flow falls into.

Gensight Biologics Price-to-Operating-Cash-Flow Calculation

Gensight Biologics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.394	/	-0.519
	=

Gensight Biologics's Share Price of today is €0.394.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gensight Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.52.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Gensight Biologics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Gensight Biologics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Gensight Biologics (XPAR:SIGHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (XPAR:SIGHT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

GSGTF:USA G49N:Germany

Address

74,rue du Faubourg Saint-Antoine, Paris, FRA, 75012

Website

https://www.gensight-biologics.com

Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence, and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group focus is on ophthalmology where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics (XPAR:SIGHT) Headlines

No Headlines